HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 29 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,689,064 | $5,506,000 | 3.35% |
| PERKINS CAPITAL MANAGEMENT INC | 249,700 | $814,000 | 0.58% |
| Private Wealth Partners, LLC | 900,000 | $2,934,000 | 0.49% |
| Diametric Capital, LP | 60,752 | $198,000 | 0.19% |
| Granahan Investment Management | 915,449 | $2,984,000 | 0.18% |
| B. Riley Wealth Advisors, Inc. | 250,000 | $815,000 | 0.11% |
| Kalos Management, Inc. | 38,000 | $137,000 | 0.06% |
| Spark Investment Management LLC | 203,600 | $663,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 199,500 | $650,000 | 0.03% |
| Crow Point Partners, LLC | 25,860 | $84,000 | 0.02% |